ArticleAlimentary pharmacology & therapeutics2021

Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing.

Tilman Emrich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.